The 20 Best WT1-Related Wilms Tumor Syndromes Doctors Near Me in Flushing, NY
Find the Top WT1-Related Wilms Tumor Syndromes Experts and Specialists
Montefiore Medical Center
Benjamin A. Gartrell, MD, is Director, Genitourinary Malignancy Program at Montefiore and an Assistant Professor of Oncology and Urology at our Albert Einstein College of Medicine. Since joining the Montefiore team in 2012, his expertise has been in treating genitourinary malignancies including prostate cancer, bladder cancer, renal cell cancer, and testicular cancer. He is also very active in translating science findings in collaboration with research colleagues at Einstein. In 2000, Dr. Gartrell received his Bachelor of Arts in Chemistry at the College of Wooster in Ohio. Following this, he attended the Northwestern University?s Feinberg School of Medicine, in Chicago, Illinois, where he received his Doctor of Medicine in 2005. His postgraduate training began in 2005 with an internship and residency in Internal Medicine at Case Western Reserve University, which he completed in 2008. He then completed a fellowship in Hematology/Oncology at Mount Sinai School of Medicine in 2012 and became Chief Fellow from 2010-2011. With a vast range of research interests, Dr. Gartrell focuses on translational research evaluating the significance of a novel immune checkpoint molecule in bladder cancer, evaluating the role of the autonomic nervous system in?prostate cancer, toxicities associated with anticancer therapies, and the impact of bone metastasis on patients with prostate cancer. His work has been published in a number of peer-reviewed journals, including the Journal of Clinical Oncology, Urologic Oncology, and European Urology. Dr. Gartrell also participates in community outreach to promote Prostate Cancer Awareness. Dr. Gartrell is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Renal Cell Carcinoma (RCC), Clear Cell Sarcoma, Nephrectomy, and Prostatectomy.
Northwell Health Physician Partners Smith Institute For Urology At Lake Success
Louis Kavoussi, MD, MBA, Director of teleintervention at Northwell. He is a world-renowned urologic surgeon who brings more than 30 years of specialized expertise in minimally invasive urological surgery. His area of focus includes treating a wide range of urologic diseases, including kidney obstructions, renal stones and urologic cancer. At the forefront of innovation, Dr. Kavoussi pioneered several new surgical techniques, including the first minimally invasive approaches to kidney surgery for kidney cancer and kidney donation. He was also part of the team that performed the first laparoscopic prostate removal for cancer. In 1999, Dr. Kavoussi received a Smithsonian Computerworld Permanent Collection award for his work in developing telerounding, the starting point of telehealth medicine-to facilitate physician communication with hospitalized patients. Before joining Northwell in 2005 as chair of urology, Dr. Kavoussi completed his medical degree at the State University of New York at Buffalo. He obtained his urologic training at Washington University of St. Louis and, directly following residency, was named chief of urology at the Jewish Hospital of St. Louis. In 1991, he was appointed assistant professor at Harvard School of Medicine and director of endourology at the Brigham and Women's Hospital. In 1993, he joined the faculty of Johns Hopkins University School of Medicine, where he was vice chairman of urology and named a Patrick C. Walsh Distinguished Professor. Dr. Kavoussi values a team approach to care, and often collaborates with other specialists to create personalized and comprehensive treatment plans. His patients appreciate his easygoing personality and thoughtfulness. As the Waldbaum-Gardner Distinguished Professor of Urology at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Dr. Kavoussi is passionate about training the next generation of surgeons. He has presented his work and given live surgical demonstrations at conferences around the world and has more than 500 academic publications. Dr. Kavoussi is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. He is also highly rated in 35 other conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, Nephrectomy, and Reconstructive Urology Surgery. Dr. Kavoussi is board certified in American Board Of Urology.
Northwell Health Physician Partners Smith Institute For Urology At Lake Success
Joph Steckel is a Urologist practicing medicine in Lake Success, New York. Dr. Steckel is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. He is also highly rated in 28 other conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), WT1-Related Wilms Tumor Syndromes, Chromophobe Renal Cell Carcinoma, Nephrectomy, and Reconstructive Urology Surgery. Dr. Steckel is board certified in American Board Of Urology.
Northwell Health Center For Advanced Medicine, RJ Zuckerberg Cancer Center
"Xinhua Zhu, MD, PhD, is a medical oncologist and hematologist at Monter Cancer Center, where he specializes in treating genitourinary cancer, including cancer of the prostate, kidney, bladder and testicles. He focuses on compassionate, evidence-based care, rooted in his research background.""My research helps me think outside the box when creating treatment plans,"" says Dr. Zhu, ""and enables me to explain to patients the mechanisms behind the treatments I'm using."" His research interests include finding new treatment targets for generating hormone resistance in prostate cancer and metastatic castration-resistant prostate cancer, exploring biomarkers in bladder cancer to guide decisions about chemotherapy, exploring the mechanisms for kidney cancer metastasis, and investigating the effectiveness of immunotherapy for genitourinary cancers.Dr. Zhu earned his medical degree at Suzhou Medical College and practiced internal medicine in China. He obtained his PhD in cancer study at Shanghai Jiao Tong University School of Medicine, then moved to the United States for postdoctoral research training at Memorial Sloan Kettering Cancer Center, an internal medicine residency at Mount Sinai School of Medicine. He attended NYU School of Medicine for fellowship training in hematology and medical oncology.In 2013, he joined Northwell Health, where he regularly meets with a multidisciplinary group of pathologists, radiologists, radiation oncologists, surgical oncologists, geneticists and the Molecular Tumor Board to create treatment plans.As an associate professor at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, he twice received the Medical Oncology/Hematology Fellowship Program Teacher of the Year Award. Dr. Zhu is also a phase 1 cancer research program director at Monter Cancer Center. He is assistant investigator at the Feinstein Institutes for Medical Research, and a member of the American Society of Clinical Oncology, the American Association of Cancer Research, and the Principal Investigator for the Northwell Health NCI Community Oncology Research Program (NCORP)For Dr. Zhu, being able to pursue both scientific investigation and patient care is the best part of his work. ""I can take research from the bench to the bedside, providing people with the best possible treatments,"" he says.". Dr. Zhu is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Non-Muscle Invasive Bladder Cancer, Muscle Invasive Bladder Cancer, Prostate Cancer, and Clear Cell Sarcoma. Dr. Zhu is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine/Hematology, and American Board Of Internal Medicine/Medical Oncology.
Northwell Health At Rego Park
Jane Cho is an Oncologist and a Urologist practicing medicine in Rego Park, New York. Dr. Cho is rated as an Experienced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. She is also highly rated in 11 other conditions, according to our data. Her clinical expertise encompasses Obstructive Uropathy, Bladder Cancer, Urinary Tract Infection (UTI), Cystectomy, and Ureteroscopy. Dr. Cho is board certified in American Board Of Urology.
Northwell Health At Rego Park
Christopher Hartman is a Urologist practicing medicine in Rego Park, New York. Dr. Hartman is rated as an Experienced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Obstructive Uropathy, Enlarged Prostate (BPH), Kidney Stones, Lithotripsy, and Ureteroscopy. Dr. Hartman is board certified in American Board Of Urology.
Memorial Sloan Kettering Cancer Center
Joshua Chaim is a Radiologist practicing medicine in New York, New York. Dr. Chaim is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses WT1-Related Wilms Tumor Syndromes, Renal Cell Carcinoma (RCC), Muscle Invasive Bladder Cancer, Ureterocele, and Prostatectomy.
Memorial Sloan Kettering Cancer Center
Anita Price is a Pediatric Radiologist practicing medicine in New York, New York. Dr. Price is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. She is also highly rated in 28 other conditions, according to our data. Her clinical expertise encompasses Pleurisy, Pleural Effusion, WT1-Related Wilms Tumor Syndromes, Pancreaticoduodenectomy, and Orchiectomy.
Memorial Sloan Kettering Cancer Center
James Fuqua is a Radiologist practicing medicine in New York, New York. Dr. Fuqua is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses WT1-Related Wilms Tumor Syndromes, Muscle Invasive Bladder Cancer, ALK-Positive Non-Small Cell Lung Cancer, and Lymphoid Hyperplasia.
Memorial Sloan Kettering Cancer Center
Debra Sarasohn is a Radiologist practicing medicine in New York, New York. Dr. Sarasohn is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. She is also highly rated in 2 other conditions, according to our data. Her clinical expertise encompasses WT1-Related Wilms Tumor Syndromes, Renal Cell Carcinoma (RCC), Ascites, and Thyroid Nodule.
Memorial Sloan Kettering Cancer Center
Omer Aras is a Radiologist practicing medicine in New York, New York. Dr. Aras is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses WT1-Related Wilms Tumor Syndromes, Muscle Invasive Bladder Cancer, Non-Muscle Invasive Bladder Cancer, Renal Cell Carcinoma (RCC), and Liver Embolization.
Memorial Sloan Kettering Cancer Center
Oguz Akin is a Radiologist practicing medicine in New York, New York. Dr. Akin is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Muscle Invasive Bladder Cancer, Non-Muscle Invasive Bladder Cancer, Nephrectomy, and Prostatectomy.
Memorial Sloan Kettering Cancer Center
Jonathan Landa is a Radiologist practicing medicine in New York, New York. Dr. Landa is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. He is also highly rated in 31 other conditions, according to our data. His clinical expertise encompasses Liposarcoma, Ganglioneuroblastoma, Rhabdoid Tumor Predisposition Syndrome, and Synovial Sarcoma.
Kai Tsao, MD, MS, is the system chief of solid tumor oncology, medical director of the R.J. Zuckerberg Cancer Center, and medical director of the medical oncology prostate cancer program at the Northwell Cancer Institute. He specializes in cancers of the genitourinary organs and has more than a decade of clinical experience. His research focuses on the development of biomarkers and novel therapies for patients with genitourinary cancers.Dr. Tsao was inspired to become an oncologist after witnessing many close family and friends suffering from cancer. He completed medical school training at SUNY Downstate, an internal medicine residency at Long Island Jewish Medical Center, and a fellowship in hematology and medical oncology at Mount Sinai Hospital. He earned a master's degree in healthcare delivery leadership at Icahn School of Medicine at Mount Sinai and completed Lean Six Sigma training at Johns Hopkins.Prior to joining Northwell, Dr. Tsao served as medical director of the Ruttenberg Treatment Center, medical director of the medical oncology prostate cancer program, and physician leader for internal oncology collaborations at the Mount Sinai Hospital, Tisch Cancer Institute. In these roles, Dr. Tsao and his team built a cancer center that is patient centered, quality driven, scientifically innovative, and provided multi-disciplinary care to patients with cancer.For me, patient care much more than the cancer diagnosis and treatment. It is essential to address the many needs of our cancer patients: emotional well-being, social support, nutrition, physical activity, financial challenges and more. We aim to provide the best support for our patients, one at a time.Dr. Tsao is an accomplished physician-scientist who has authored more than 80 peer-reviewed publications in the field of genitourinary oncology. He serves as associate editor of Genitourinary Oncology, Frontiers in Oncology. His leadership in carrying out complex clinical trials in targeted therapies and immunotherapies positions his patients at the forefront of cutting-edge cancer research and patient-centered care.What I most enjoy every day is seeing patients under our care, despite the devastation of their cancer diagnosis, beating their cancer and living a life that was not considered a possibility years ago. Our mission at Northwell Cancer Institute is to make this a reality for every single patient. Dr. Tsao is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, Orchiectomy, and Nephrectomy. Dr. Tsao is board certified in American Board Of Internal Medicine/Medical Oncology.
New York Hospital Medical Center Of Queens
Yong Hahn is a Radiologist practicing medicine in Flushing, New York. Dr. Hahn is rated as an Experienced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Progressive Familial Intrahepatic Cholestasis Type 2, Progressive Familial Intrahepatic Cholestasis Type 3, Progressive Familial Intrahepatic Cholestasis Type 1, and Bronchogenic Cyst.
New York Hospital Medical Center Of Queens
Iakovos Koutras is a Radiologist practicing medicine in Flushing, New York. Dr. Koutras is rated as an Experienced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. He is also highly rated in 20 other conditions, according to our data. His clinical expertise encompasses Progressive Familial Intrahepatic Cholestasis Type 3, Progressive Familial Intrahepatic Cholestasis Type 2, Progressive Familial Intrahepatic Cholestasis Type 1, and Jaundice.
New York Hospital Medical Center Of Queens
John Iraj is a Radiologist practicing medicine in Flushing, New York. Dr. Iraj is rated as an Experienced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Progressive Familial Intrahepatic Cholestasis Type 1, Progressive Familial Intrahepatic Cholestasis Type 3, Progressive Familial Intrahepatic Cholestasis Type 2, and Berdon Syndrome.
New York Hospital Medical Center Of Queens
Jeremy Neuman is a Pediatric Radiologist practicing medicine in Flushing, New York. Dr. Neuman is rated as an Experienced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Gallbladder Disease, Visceromegaly, Progressive Familial Intrahepatic Cholestasis Type 1, and Progressive Familial Intrahepatic Cholestasis Type 2.
New York Hospital Medical Center Of Queens
John Derosa is a Radiologist practicing medicine in Flushing, New York. Dr. Derosa is rated as an Experienced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Osteopenia, Melorheostosis with Osteopoikilosis, Melorheostosis, Gastrostomy, and Endoscopy.
LYNN Ang
Gregory Grimaldi is a Radiologist practicing medicine in Forest Hills, New York. Dr. Grimaldi is rated as an Experienced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Progressive Familial Intrahepatic Cholestasis Type 1, Progressive Familial Intrahepatic Cholestasis Type 2, Progressive Familial Intrahepatic Cholestasis Type 3, Small Bowel Resection, and Endoscopy.
Last Updated: 04/28/2026





